glutathione parkinson's disease therapy perlmutter Randomized, double‐blind, pilot evaluation of intravenous in - Hauser - 2009 - Movement Disorders Frontiers | From pathogenesis to

Multiple clinical trials and controlled studies have demonstrated: Statistically significant improvements in skin firmness and elasticity with consistent use Reduction in fine lines and wrinkle depth over 3-6 months of application Improved skin density, moisture retention, and surface texture Reduction in photodamage and hyperpigmentation Tightening of loose skin documented in both topical and injectable applications Citation: Leyden JJ et al

[66] TGF- also blocks B cell activation and promotes class switching IgA in both human and mouse B cells and has an otherwise inhibitory function for antibody production

In animal model studies, the product is used to explore NNMTmediated regulation of wholebody energy metabolism

Cancer Res 79:59205929